Screening compound: YTTLZKNFLDSTNU-FQEVSTJZSA-N

Screening compound: YTTLZKNFLDSTNU-FQEVSTJZSA-N
Screening compound: YTTLZKNFLDSTNU-FQEVSTJZSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
YTTLZKNFLDSTNU-FQEVSTJZSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P681-0244

Molecular Formula

C20H17N3O3 (C20 H17 N3 O3)

Compound Name

4-[(5-methoxy-2-oxo-1,2-dihydro-1'H-spiro[indole-3,3'-pyrrolidin]-1'-yl)carbonyl]benzonitrile

IUPAC name

4-({5-methoxy-2-oxo-12-dihydrospiro[indole-33'-pyrrolidin]-1'-yl}carbonyl)benzonitrile

SMILES

COc(cc1)cc(C2(CC3)CN3C(c(cc3)ccc3C#N)=O)c1NC2=O

MDL Number (MFCD)

YTTLZKNFLDSTNU-FQEVSTJZSA-N in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Integrin Receptors Targeted library (1715 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein-Protein Interaction Library (218420 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Spiro Library (21655 compounds)

Antibacterial Compounds Library (13827 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Infections
  • Immune system
  • animal
  • Cancer
Targets:
  • Others
  • Nuclear receptors
  • Proteases
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with YTTLZKNFLDSTNU-FQEVSTJZSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound YTTLZKNFLDSTNU-FQEVSTJZSA-N?
Check Price and Availability of YTTLZKNFLDSTNU-FQEVSTJZSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of YTTLZKNFLDSTNU-FQEVSTJZSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for YTTLZKNFLDSTNU-FQEVSTJZSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for YTTLZKNFLDSTNU-FQEVSTJZSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of YTTLZKNFLDSTNU-FQEVSTJZSA-N available by request